Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice

Abstract Antiviral treatment options for chronic Hepatitis E Virus (HEV) infections are limited and immunological determinants of viral persistence remain largely unexplored. We studied the antiviral potency of pegylated interferon-α (pegIFNα) against HEV infections in humanized mice and modelled in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Martijn D. B. van de Garde, Suzan D. Pas, Gertine W. van Oord, Lucio Gama, Youkyung Choi, Robert A. de Man, Andre Boonstra, Thomas Vanwolleghem
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/92e4c668c29940759340cefbb3ea2515
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:92e4c668c29940759340cefbb3ea2515
record_format dspace
spelling oai:doaj.org-article:92e4c668c29940759340cefbb3ea25152021-12-02T16:07:58ZInterferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice10.1038/s41598-017-07434-y2045-2322https://doaj.org/article/92e4c668c29940759340cefbb3ea25152017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07434-yhttps://doaj.org/toc/2045-2322Abstract Antiviral treatment options for chronic Hepatitis E Virus (HEV) infections are limited and immunological determinants of viral persistence remain largely unexplored. We studied the antiviral potency of pegylated interferon-α (pegIFNα) against HEV infections in humanized mice and modelled intrahepatic interferon stimulated gene (ISG) responses. Human gene expression levels in humanized mouse livers were analyzed by qPCR and Nanostring. Human CXCL10 was measured in mouse serum. HEV genotype 3 (gt3) infections were cleared from liver and feces within 8 pegIFNα doses in all mice and relapsed after a single pegIFNα injection in only half of treated animals. Rapid viral clearance by pegIFNα was confirmed in HEV gt1, but not in Hepatitis B Virus infected animals. No ISG induction was observed in untreated HEV gt3 and gt1 infected humanized livers compared to control chimeric mice, irrespective of the human hepatocyte donor, viral isolate or HEV infection duration. Human specific ISG transcript levels in mouse liver increased significantly after pegIFNα treatment and induced high circulating human CXCL10 in mouse serum. In conclusion, HEV gt1 and gt3 infections do not elicit innate intrahepatic immune responses and remain highly sensitive to pegIFNα in immunocompromised humanized mice.Martijn D. B. van de GardeSuzan D. PasGertine W. van OordLucio GamaYoukyung ChoiRobert A. de ManAndre BoonstraThomas VanwolleghemNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Martijn D. B. van de Garde
Suzan D. Pas
Gertine W. van Oord
Lucio Gama
Youkyung Choi
Robert A. de Man
Andre Boonstra
Thomas Vanwolleghem
Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice
description Abstract Antiviral treatment options for chronic Hepatitis E Virus (HEV) infections are limited and immunological determinants of viral persistence remain largely unexplored. We studied the antiviral potency of pegylated interferon-α (pegIFNα) against HEV infections in humanized mice and modelled intrahepatic interferon stimulated gene (ISG) responses. Human gene expression levels in humanized mouse livers were analyzed by qPCR and Nanostring. Human CXCL10 was measured in mouse serum. HEV genotype 3 (gt3) infections were cleared from liver and feces within 8 pegIFNα doses in all mice and relapsed after a single pegIFNα injection in only half of treated animals. Rapid viral clearance by pegIFNα was confirmed in HEV gt1, but not in Hepatitis B Virus infected animals. No ISG induction was observed in untreated HEV gt3 and gt1 infected humanized livers compared to control chimeric mice, irrespective of the human hepatocyte donor, viral isolate or HEV infection duration. Human specific ISG transcript levels in mouse liver increased significantly after pegIFNα treatment and induced high circulating human CXCL10 in mouse serum. In conclusion, HEV gt1 and gt3 infections do not elicit innate intrahepatic immune responses and remain highly sensitive to pegIFNα in immunocompromised humanized mice.
format article
author Martijn D. B. van de Garde
Suzan D. Pas
Gertine W. van Oord
Lucio Gama
Youkyung Choi
Robert A. de Man
Andre Boonstra
Thomas Vanwolleghem
author_facet Martijn D. B. van de Garde
Suzan D. Pas
Gertine W. van Oord
Lucio Gama
Youkyung Choi
Robert A. de Man
Andre Boonstra
Thomas Vanwolleghem
author_sort Martijn D. B. van de Garde
title Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice
title_short Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice
title_full Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice
title_fullStr Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice
title_full_unstemmed Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice
title_sort interferon-alpha treatment rapidly clears hepatitis e virus infection in humanized mice
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/92e4c668c29940759340cefbb3ea2515
work_keys_str_mv AT martijndbvandegarde interferonalphatreatmentrapidlyclearshepatitisevirusinfectioninhumanizedmice
AT suzandpas interferonalphatreatmentrapidlyclearshepatitisevirusinfectioninhumanizedmice
AT gertinewvanoord interferonalphatreatmentrapidlyclearshepatitisevirusinfectioninhumanizedmice
AT luciogama interferonalphatreatmentrapidlyclearshepatitisevirusinfectioninhumanizedmice
AT youkyungchoi interferonalphatreatmentrapidlyclearshepatitisevirusinfectioninhumanizedmice
AT robertademan interferonalphatreatmentrapidlyclearshepatitisevirusinfectioninhumanizedmice
AT andreboonstra interferonalphatreatmentrapidlyclearshepatitisevirusinfectioninhumanizedmice
AT thomasvanwolleghem interferonalphatreatmentrapidlyclearshepatitisevirusinfectioninhumanizedmice
_version_ 1718384671636586496